Cefotetan

Cefotetan

File:Cefotetan.svg
Clinical data
ATC code	J01DC05 (WHO)
Identifiers
IUPAC name (7S)-7-{[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene) 1,3-dithietane-2-carbonyl]amino}-7-methoxy- 3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	69712-56-7
PubChem CID	50614
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C17H17N7O8S4
Molar mass	575.623 g/mol

WikiDoc Resources for Cefotetan
Articles
Most recent articles on Cefotetan Most cited articles on Cefotetan Review articles on Cefotetan Articles on Cefotetan in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefotetan Images of Cefotetan Photos of Cefotetan Podcasts & MP3s on Cefotetan Videos on Cefotetan
Evidence Based Medicine
Cochrane Collaboration on Cefotetan Bandolier on Cefotetan TRIP on Cefotetan
Clinical Trials
Ongoing Trials on Cefotetan at Clinical Trials.gov Trial results on Cefotetan Clinical Trials on Cefotetan at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefotetan NICE Guidance on Cefotetan NHS PRODIGY Guidance FDA on Cefotetan CDC on Cefotetan
Books
Books on Cefotetan
News
Cefotetan in the news Be alerted to news on Cefotetan News trends on Cefotetan
Commentary
Blogs on Cefotetan
Definitions
Definitions of Cefotetan
Patient Resources / Community
Patient resources on Cefotetan Discussion groups on Cefotetan Patient Handouts on Cefotetan Directions to Hospitals Treating Cefotetan Risk calculators and risk factors for Cefotetan
Healthcare Provider Resources
Symptoms of Cefotetan Causes & Risk Factors for Cefotetan Diagnostic studies for Cefotetan Treatment of Cefotetan
Continuing Medical Education (CME)
CME Programs on Cefotetan
International
Cefotetan en Espanol Cefotetan en Francais
Business
Cefotetan in the Marketplace Patents on Cefotetan
Experimental / Informatics
List of terms related to Cefotetan

Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe converage.

Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan.

External links

• Cefotan official web site run by AstraZeneca US
• Cefotetan entry in RxList

th:เซโฟตีแทน